Stabilizing agents and capture ligands for use in assays...

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S007500, C435S007920, C436S523000, C436S526000, C530S389800, C568S028000

Reexamination Certificate

active

07897352

ABSTRACT:
The present invention is related to compositions useful for the measurement of free or unbound analyte concentrations in a fluid. The present invention includes the use of capture ligands and stabilizing agents to improve the accuracy of analyte concentration assays. Methods and tools for using the present invention are also disclosed.

REFERENCES:
patent: 4946778 (1990-08-01), Ladner et al.
patent: 5770380 (1998-06-01), Hamilton et al.
patent: 2003/0134325 (2003-07-01), Cubicciotti
patent: 2003/0228681 (2003-12-01), Ritts et al.
patent: 2005/0077497 (2005-04-01), Anderson
patent: 2005/0110989 (2005-05-01), Schermer et al.
patent: 2005/0260666 (2005-11-01), Nahm et al.
patent: 2005/0287197 (2005-12-01), Kurtz
patent: 0240021 (1987-10-01), None
patent: 1 207 393 (2002-05-01), None
Richardson et al. The use of coated paramagnetic particles as a physical label in magneto-immunoassay. Biosensors & Bioelectronics 2001, vol. 16, pp. 989-993.
Oellerich. Enzyme immunoassay, A review. 1984, vol. 22, pp. 895-904.
Beckman Coulter, “Access Immunoassay Systems Total T4: Ref. 33800,” 387031B:1-9, Beckman Coulter, Inc. (Jun. 2006).
Cheng, S.-Y., et al., “Analysis of Thyroid Hormone Binding to Human Serum Prealbumin by 8-Anilinonaphthalene-1-sulfonate Fluorescence,”Biochem. 16:3707-3713, American Chemical Society (1977).
Clejan, S., et al., “Influence of Growth Hormone and Thyroxine of Thermotropic Effects of Respiration and 1-Anilino-8-Naphthalene Sulfonate Fluorescene and on Lipid Composition of Cardiac Membranes,”Biochim. Biophys. Acta 678:250-256, Elsevier/North-Holland Biomedical Press (1981).
Hsieh-Wilson, L.C., et al., “Lessons from the Immune System: From Catalysis to Materials Science,”Acc. Chem. Res. 29:164-170, American Chemical Society (1996).
Inoue, K., et al., “Perfluorooctane Sulfonate (PFOS) and Related Perfluorinated Compounds in Human Maternal and Cord Blood Samples: Assessment of PFOS Exposure in a Suspectible Population during Pregnancy,”Environ. Health Perspect. 112:1204-1207, National Institute of Environmental Health Sciences (2004).
Kragh-Hansen, U., et al., “IV. Relation Between Binding of Phenolsulfophthalein Dyes and other Ligands with a High Affinity for Human Serum Albumin,”Biochim. Biophys. Acta 365:360-371, Elsevier Scientific Publishing Company, Amsterdam (1974).
Malkus, H., and Donabedian, R.K., “Triiodothyronine Radioimmunoassay: A Study of the Interactions of T3 with Anti-T3 Antisera and with Thyroxine Binding Globulin in the Presence of ANS (Ammonium-8-Anilino Naphthalene-1-Sulfonate,”Clin. Chim. Acta 51:191-198, Elsevier Scientific Publishing Company (1974).
McLean, M., et al., “Cation-exchange resin and inhibition of intestinal absorption of thyroxine,”Lancet 341:1286, Lancet Publishing Group (1993).
Morisson, S.L., et al., “Chimeric human antibody molecules: Mouse antigen-binding domains with human constant region domains,”Proc. Natl. Acad. Sci. USA 81:6851-6855, National Academy of Sciences (1984).
Neuberger, M.S., et al., “Recombinant antibodies possessing novel effector functions,”Nature 312:604-608, Macmillan Journals Ltd. (1984).
Nilsson, S.F., and Peterson, P.A., “Studies on Thyroid Hormone-binding Proteins. I. The Subunit Structure of Human Thyroxine-Binding Globulin and Its Interaction with Ligands,”J. Biol. Chem. 250:8543-8553, American Society for Biochemistry and Molecular Biology (1975).
Painter, K., and Vader, C.R., “Interference of Iodine-125 Ligands in Radioimmunoassay: Evidence Implicating Thyroxine-Binding Globulin,”Clin. Chem. 25:797-799, American Association For Clinical Chemistry (1979).
van Jaarsveld, P.P., et al., “Polymorphism of Rhesus Monkey Serum Prealbumin,”J. Biol. Chem. 248:4706-4712, American Society for Biochemistry and Molecular Biology (1978).
Verhoeyen, M.E., and Windust, J.H.C., “Advances in antibody engineering,” inMolecular Immunology 2nd ed., Hames, B.D., and Glover, D.M., eds., IRL Press, Oxoford University Press, pp. 283-325 (1996).
3M, “Fc-100 Fluorad Brand Fluorochemical Surfactant,”Material Safety Data Sheet, 7 pages, 3M Company (2000).
International Search Report for International Application No. PCT/US2007/016420, mailed on Apr. 17, 2008, United States Patent Office, Alexandria, Virginia.
Written Opinion for International Application No. PCT/US2007/016420, mailed on Apr. 17, 2008, United States Patent Office, Alexandria, Virginia.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Stabilizing agents and capture ligands for use in assays... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Stabilizing agents and capture ligands for use in assays..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stabilizing agents and capture ligands for use in assays... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2703480

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.